Comparison of risk factors among blood donors, volunteers and replacement individuals, infected or not by hepatitis c virus

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 15, Issue 1, 2009, Pages 103-124

  Felippe, Maria Justina D B ^a   Meira, D A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Alcohol; Blood donors; Hepatitis C; Injectable drugs; Marijuana; Risk factors; Sexual behavior; Tobacco

Indexed keywords

ILLICIT DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; AMBULATORY CARE; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL EVALUATION; CONDOM; CONTRACEPTION; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HEALTH CARE POLICY; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PATIENT MONITORING; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALITY; SMOKING; TATTOOING; TOBACCO; VIRUS TRANSMISSION;

CANNABIS SATIVA; HEPATITIS C VIRUS; NICOTIANA TABACUM;

EID: 65849241942     PISSN: 16789199     EISSN: 16789199     Source Type: Journal    
DOI: 10.1590/S1678-91992009000100010     Document Type: Article

References (48)

1. Labedzka H, Simon K, Gladysz A. Clinical and epidemiological assessment of hepatitis C virus infection among voluntary blood donors. Med Sci Monit. 2002;8(8):591-596
2. Lazzarini FAS, Andrade D, Rossi LA, Ferraz AEP. Incidência de soroconversão para o vírus da hepatite C após a implementação de programa de prevenção e controle em unidades de hemodiálise. Rev Lat Am Enfermagem. 2000;8(5):7-12.
3. Mathei C, Robaeys G, van Damme P, Buntinx F, Verrando R. Prevalence of hepatitis C in drug users in Flanders: determinants and geographic differences. Epidemiol Infect. 2005;133(1):127-136 (Pubitemid 40276983)
4. Mcmahon JM, Simm M, Milano D, Clatts M. Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. Ann Clin Microbiol Antimicrob. 2004; 3:6-10.
5. Memon MI, Memon MA. Hepatitis C: an epidemiological review. J Viral Hepat. 2002;9(2):84-100.
6. NHI Consensus statement on management of hepatitis C: 2002. NIH Consens State Sci Statements. 2002;19(3):1-46.
7. Oliveira LC, Buso AG, Oliveira AT, Arantes CA, Borges LV, Valente SR. Prevalence of hepatitis B and hepatitis C markers in alcoholics with and without clinically evident hepatic cirrhosis. Rev Inst Med Trop São Paulo. 1999;41(2):69-73.
8. Oliveira MLA, Bastos FI, Telles PR, Yoshida CFT, Schatzmayr MG, Paetzold U, Pauli G, Schreier E. Prevalence and risk factors for HBV, HCV and HIV infections among injecting drug users from Rio de Janeiro, Brazil. Braz J Med Biol Res. 1999;32(9):1107-1114
9. a Sessão do Comitê Executivo. Fortalecimento dos Bancos de Sangue na Região das Américas, abril 1999 [Internet]. [place unknown]; 2004 [cited 2004 Jul 09] . Available from: http://www.bases.bireme.br/chi-oms/cd124.16/iah/ online.
10. Paltanin LF, Reiche EM. Seroprevalence of anti-hepatitis C virus antibodies among blood donors, Brazil. Rev Saúde Pública. 2002;36(4):393-399 (Pubitemid 35314685)
11. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, Rueff B, Valla DC, Degos F. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology. 2001,34(1):121-125
12. Phillips CV, Wang C, Guenzel B. You might as well smoke; the misleading and harmful public message about smokeless tobacco. BMC Public Health. 2005;5:31-38 (Pubitemid 40958319)
13. Simmonds P, Zhang LQ, Watson HG, Rebus S, Ferguson ED, Balfe P, Leadbetter GH, Yap PL, Peutherer JF, Ludlam CA. Hepatitis C quantification in sequencing in blood products, hemophiliacs and drug users. Lancet. 1990;336(8729):1469-1472
14. Souza M, Vianna LAC. Incidência de acidentes de trabalho relacionada com a não utilização das precauções universais. Rev Bras Enfermagem. 1993;46(3-4):234-244
15. Strauss E. Hepatitis C. Rev Soc Bras Med Trop. 2001;34(1):69-82.
16. Terrault N. Chronic viral hepatitis in the United States. American Association for the Study of Liver Diseases [Internet]. An update: viral hepatitis, October 2000. [cited 2003 Out 20]. Available from:http://www.hepnet. com/hepc/aasld00/terrault.html.
17. Vassilev ZP, Strauss SM, Astone J, Des Jarlais DC. Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs. J Behav Health Serv Res. 2004;31(2):208-216
18. Velasco M, Poniachik J, Alegria S, Brahm J. Transmisión familiar del virus de la hepatitis C en un grupo de población chilena. Rev Med Chile. 2003;131(10):1123-1127
19. Wang CS, Chang TT, Yao WJ, Chou P. Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study. Am J Trop Med Hyg. 2002;66(4):389-393
20. WejstaL R. Sexual transmission of hepatitis C virus. J Hepatol. 1999;31:92-95
21. Wendel S, Luzzi JR, Russo C, Fontão RCL, Ghaname J. Pesquisa de anti-HBc em doadores de sangue em São Paulo: deverá esse teste ser adotado pelo Brasil? Rev Paul Med. 1991;109:77-83.
22. WHO. World Health Organization. Fact sheet n. 164: hepatitis C [Internet]. [cited 2004 Jun 18]. Available from http://www.who.int/inf-fact164. html.
23. Williams I. Epidemiology of hepatitis C in the United States. Am J Med. 1999;107(6B):2-9.
24. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244(4902):359-362 (Pubitemid 19117877)
25. Gonçales Jr FL, Stucchi RS, Pavan MH, Escanhoela CA, Yamanaka A, Magna LA, Gonçales NS. A clinical, epidemiological, laboratorial, histological and ultrasonographic evaluation of anti-HCV EIA-2 positive blood donors. Rev Inst Med Trop São Paulo. 2000;42(3):147-152
26. Coelho HS, Figueiredo FA, Segadas JÁ, Panaim VL, Nogueira CM, Silva CR, Mussi TJ. Evolutive aspects of post-transfusion hepatitis C. Review of 175 cases. Rev Soc Bras Med Trop. 1998;31(3):295-300.
27. Instituto Brasileiro de Geografia e Estatística. Análise das cidades brasileiras quanto à distribuição da população [Internet]. [cited 2004 Nov 04]. Available from http://www.ibge.gov.br.
28. Grupo dos Alcoólicos Anônimos de São Paulo. Índices e dosagens alcoólicas [Internet]. [cited 2004 May 14]. Available from http://www.gaasp.com.br.
29. Cury PR. Metodologia e análise de pesquisa em ciências biológicas. 2nd ed. Botucatu: Editora Tipomic; 1997. 315 p.
30. Armas-Merino R, Wolff Fernandez C, Soto Henriquez R, Jirón Vargas MI, Parraguez Abarca A. El virus C de la hepatitis y las enfermedades que produce. Rev Med Chile. 1999;127(10):1240-1254
31. Hospital Estadual Bauru. Eventos e Promoções [Internet]. [cited 2005 Jul 09]. Available from http://www.heb.bauru.unesp.br.
32. Focaccia R, Siciliano RF, Santos ED, Boccardo E, Conceição OJ, Barbosa UO, Galante VC. Hepatitis C: a critical analysis of therapeutic response predictors. Braz J Infect Dis. 2002;6(2):74-81.
33. Güemes MA, Chil OA, Estévez AV, Valverde CV. Comportamiento de la hepatitis C en donantes de sangre. Rev Cubana Hig Epidemiol. 2001;39(2):82-85
34. Brandão AB, Fuchs SC. Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study. BMC Gastroenterol. 2002;2:18.
35. Arraes LC, Ximenes R, Andrieu JM, Lu W, Barreto S, Pereira LMMB, Castelo A. The biological meaning of anti-HBc positive results in blood donor: relation to HBV-DNA and to other serological markers. Rev Inst Med Trop São Paulo. 2003;45(3):137-140 (Pubitemid 36876482)
36. Drawan VK, Wu GY, Talavera F, Brann OS, Mechaber AJ, Katz J. Hepatitis C (protocol for a Cochrane Review). In: The Cochrane Library Plus. Issue 16, 2004. Oxford: Update Software.
37. Figueiredo ECQ, Cotrim HP, Tavares-Neto J. Freqüência do vírus da hepatite C em profissionais da saúde: revisão sistemática da literatura. Gastroenterol Endosc Dig. 2003;22(2):53-60. (Pubitemid 36976986)
38. Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004;127(5, Suppl 1):72-78
39. ACS Quitting Smokeless Tobacco. American Cancer Society prevention and early detection [Internet]. [cited 2005 Sep 07]. Available from http://www.cancer.org/croot/content/Acessed.
40. Alter HJ, Conry-Cantilena C, Melpolder J, Tan D, van Raden M, Herion D, Lau D, Hoofnagle JH. Hepatitis C in asymptomatic blood donors. Hepatology. 1997;26(3 Suppl 1):29-33.
41. Henderson DK. Managing occupational risks for hepatitis C transmission in the health care setting. Clin Microbiol Rev. 2003;16(3):546-568
42. Hepburn MJ, Lawitz EJ. Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti. BMC Gastroenterol. 2004;4:31-34
43. Bosia JD, Rivero Altamiranda A, Coccozella DR, Diaz Velez L, Barrio M, Borzi S, Malca MI, Gonzalez JE, Munne MJ, Tonelli E, Fraquelli E, Curciarello JO. Sexual transmission of Hepatitis C virus. Acta Gastroenterol Latinoam. 2002;32(2):87-90.
44. Haley RW, Fischer RP. The tattooing paradox: are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection? Arch Intern Med. 2003;163(9):1095-1098
45. Garassini Serra M, Garassini Chávez M. Hepatitis C: how is it transmitted? Can it be prevented? GEN. 2000;54:116-135
46. Ferreira CT, Silveira TR. Viral hepatitis: epidemiological and preventive aspects. Rev Bras Epidemiol. 2004;7(4):473-487
47. Gongora DVN. Serologic markers of hepatitis C virus infection among house-staff and patients of the dialysis unit of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Rev Soc Bras Med Trop. 1998;31:585-586
48. Hepatitis C Division Health Canada. Special report on youth, piercing, tattooing and hepatitis C trendscan findings [Internet]. [cited 2005 Sep 08]. Available from http://www.healthcanada.ca/hepc.